Ari, Ferda <br/><br/>
Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.  [electronic resource] 

 -  Cell biochemistry and function  Dec 2011 
 - 651-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-0844 
<br/><br/><label>Standard No.: </label>10.1002/cbf.1801  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anthracyclines--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Azacitidine--analogs & derivatives<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>DNA Methylation--drug effects<br/>Decitabine<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Neoplasm Invasiveness<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Urokinase-Type Plasminogen Activator--genetics